Thus, IL-6, IL-10, and TNF-α have been significantly decreased, inhibiting the growth and migration of melanoma cells, suggesting the potential of the two compounds tested to be used as antitumor drugs targeting inflammatory cytokines [110]. Here, IL10 is linked to melanoma.